Építés alatt – nem éles oldal
Belépés

NCT07750834Befejeződött

Implementation and Assessment of a Medication Therapy Management Program in HIV Patients at High Risk of Adverse Drug Events at Khartoum, Sudan

Forrás: ClinicalTrials.gov · Utoljára frissítve: 2026. aug. 10.

Következő lépések

Rövid összefoglaló (regiszter, angolul)

This clinical trial aims to evaluate the effectiveness and cost-effectiveness of two levels of a pharmacist-led Medication Therapy Management (MTM) program, Basic MTM and Enhanced MTM, compared with usual care for HIV patients at high risk of adverse drug events in Khartoum, Sudan. The primary objective is to determine whether Basic MTM or Enhanced MTM improves medication adherence, measured by the Proportion of Days Covered (PDC ≥95%) at the primary 6-month assessment, with follow-up continuing for 24 months. Secondary objectives include evaluating the effects of the interventions on viral load suppression, CD4+ cell count, adverse drug events, drug-related problems, health-related quality of life, patient satisfaction, treatment self-efficacy, and cost-effectiveness. Participants will be randomly assigned in a 1:1:1 ratio to one of three study groups: Arm 1: Usual Care Arm 2: Basic Medication Therapy Management (Basic MTM) Arm 3: Enhanced Medication Therapy Management (Enhanced MTM) All participants will attend study visits at baseline and at 6, 12, 18, and 24 months to complete study questionnaires and undergo routine clinical assessments, including viral load and CD4+ measurements. Participants assigned to the Basic MTM group will receive usual care plus structured pharmacist-led Medication Therapy Management, including comprehensive medication reviews, a personal medication record, a medication action plan, five face-to-face MTM visits (baseline and every six months thereafter), and four scheduled telephone follow-up calls over the 24-month study period. Participants assigned to the Enhanced MTM group will receive all components of Basic MTM together with more frequent face-to-face visits, monthly during the first three months and every three months thereafter, additional telephone support for high-risk participants, adherence support tools (such as pill organizers and medication reminder tools), enhanced communication with prescribers, and home visits when appropriate. Do these MTM interventions improve clinical outcomes, such as viral load suppression and CD4+ cell count, compared to usual care? Researchers will compare three groups (Arm 1: Usual Care; Arm 2: Basic MTM; Arm 3: Enhanced MTM) to determine whether the MTM interventions lead to better medication adherence, fewer adverse drug events, improved quality of life, and greater cost-effectiveness. Participants will: Be randomly assigned to one of three groups: Usual Care, Basic MTM, or Enhanced MTM. Attend scheduled research assessment visits at baseline, 6, 12, 18, and 24 months to complete questionnaires (on adherence, quality of life, etc.) and provide blood samples for routine lab tests (viral load, CD4 count). If assigned to Basic MTM: Participate in 4 face-to-face sessions and 4 telephone follow-ups with a trained pharmacist over 24 months for medication reviews, education, and adherence support. If assigned to Enhanced MTM: Participate in 8 face-to-face sessions and 8 telephone follow-ups with a trained pharmacist over 24 months, and receive enhanced support tools (e.g., pillboxes, alarm devices) and potentially home visits.

Állapot (regiszter)
Befejeződött
Vizsgálattípus
Beavatkozással járó
Résztvevők száma
1149 (tényleges)
Első benyújtás
2026. ápr. 13.
Kezdés
2021. jan. 1.
Elsődleges befejezés
2023. jan. 1.
Fő szponzor
Universiti Sains Malaysia
Betegségek
HIV-fertőzés
NCT-szám
NCT07750834

Mit vállalsz

  • Vizsgálat típusa: Beavatkozással járó
  • Bevont résztvevők: 1149
  • 2021. jan. 1. és az elsődleges befejezés (2023. jan. 1.) között
  • 1 helyszín, 1 országban
  • Vizitek és vizsgálatok: kérdezd a vizsgálat csapatát, a regiszter nem sorolja fel őket

A(z) ClinicalTrials.gov regisztermezőiből összeállítva. A vizsgálat felépítését írja le.

Ki nem vehet részt

Szó szerint a(z) ClinicalTrials.gov forrásból, témák szerint csoportosítva. Hogy ki vehet részt, azt csak a vizsgálat csapata dönti el.

Korábbi kezelés

  • Concurrent participation in another pharmacological intervention study.
  • Previous participation in a formal Medication Therapy Management (MTM) program within the past year.

Más betegség

  • Significant cognitive impairment preventing informed consent or study participation.
  • Terminal illness with expected life expectancy <12 months.

Életkor

  • Age <18 years.

Egyéb

  • Pregnancy.
  • Planned relocation away from Khartoum State during the follow-up period.
  • Inability to provide informed consent for any reason.

Kiket keres a vizsgálat

  • Age: ≥18 years at the time of enrollment.
  • HIV Status: Laboratory-confirmed HIV infection.
  • ART Duration: Receiving antiretroviral therapy (ART) for at least 3 months prior to enrollment.
    • --Language and Consent: Able to communicate in Arabic or English and willing and able to provide written informed consent.
  • High-Risk Status: Meeting at least 2 of the following high-risk criteria:
  • Receiving ≥8 chronic medications, including ART and medications for comorbidities.
  • Having ≥3 chronic comorbidities (e.g., diabetes mellitus, hypertension, hepatitis, or tuberculosis).
  • Documented or self-reported adverse drug event within the previous 12 months.
  • Viral load >200 copies/mL during the previous 6 months.
    • --Self-reported medication adherence <95% or repeated missed clinic appointments.
  • Attendance at the participating HIV clinic on at least 2 occasions during the assessment period.

Életkor a regiszterben: 18 év – - · Nem: nők és férfiak · Egészséges önkénteseket nem fogad

A teljes feltétellista: ClinicalTrials.gov

Helyszínek (1)

Helyszínek a regiszter sorrendjében. Ha a profilodba mented a városodat, távolság szerint rendeződnek.

HelyszínVárosOrszágHelyszín állapota
Omdurman teaching HospitalKhartoumSzudánIsmeretlen állapot

Te vagy a koordinátor? Erősítsd meg az adatokat

Ez az oldal tájékoztatás, nem orvosi tanács. Bármely vizsgálatról az orvosoddal beszélj.